Importantly, the administration of formulations containing siLat4 could reduce the expression of Lat4 at the tumor nodes, among which the fluorination modification significantly enhanced the gene silencing efficiency (Figure 5I,J). This evidence concerns the gene SLC43A2 and neoplasm.